Leadless pacemakers in critically ill patients requiring prolonged cardiac pacing: A multicenter international study

Temporary transvenous pacing in critically ill patients requiring prolonged cardiac pacing is associated with a high risk of complications. We sought to evaluate the safety and efficacy of self‐contained intracardiac leadless pacemaker (LPM) implantation in this population.

[1]  R. Knops,et al.  A comprehensive scoping review on transvenous temporary pacing therapy , 2019, Netherlands Heart Journal.

[2]  S. Eid,et al.  Complications and Outcomes of Temporary Transvenous Pacing: An Analysis of > 360,000 Patients From the National Inpatient Sample , 2019, Chest.

[3]  P. Roberts,et al.  Leadless Pacemaker Implantation in Hemodialysis Patients: Experience With the Micra Transcatheter Pacemaker. , 2019, JACC. Clinical electrophysiology.

[4]  P. Roberts,et al.  Leadless pacemaker implant in patients with pre‐existing infections: Results from the Micra postapproval registry , 2019, Journal of cardiovascular electrophysiology.

[5]  D. Brieger,et al.  Outcomes of 4838 patients requiring temporary transvenous cardiac pacing: A statewide cohort study. , 2018, International journal of cardiology.

[6]  P. Neužil,et al.  Accelerometer-based atrioventricular synchronous pacing with a ventricular leadless pacemaker: Results from the Micra atrioventricular feasibility studies. , 2018, Heart rhythm.

[7]  P. Roberts,et al.  A leadless pacemaker in the real-world setting: The Micra Transcatheter Pacing System Post-Approval Registry. , 2017, Heart rhythm.

[8]  Rolf Haagensen,et al.  Charlson comorbidity index derived from chart review or administrative data: agreement and prediction of mortality in intensive care patients , 2017, Clinical epidemiology.

[9]  N. Prasad,et al.  The “dilemma of double lifelines”: central venous catheter co-existence with transvenous cardiac pacemaker , 2017, The journal of vascular access.

[10]  D. Annane,et al.  Cardiac implantable electronic devices in tracheotomized muscular dystrophy patients: Safety and risks. , 2016, International journal of cardiology.

[11]  C. Steinwender,et al.  Leadless Cardiac Pacemaker Implantation After Lead Extraction in Patients With Severe Device Infection , 2016, Journal of cardiovascular electrophysiology.

[12]  Josep Brugada,et al.  A Leadless Intracardiac Transcatheter Pacing System. , 2016, The New England journal of medicine.

[13]  Vivek Y. Reddy,et al.  Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker. , 2015, The New England journal of medicine.

[14]  M. Falagas,et al.  Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[15]  D. Musher,et al.  Device-related infective endocarditis, with special consideration of implanted intravascular and cardiac devices in a predominantly male population , 2012, Scandinavian journal of infectious diseases.

[16]  P. Marik,et al.  The risk of catheter-related bloodstream infection with femoral venous catheters as compared to subclavian and internal jugular venous catheters: A systematic review of the literature and meta-analysis* , 2012, Critical care medicine.

[17]  S. Lemeshow,et al.  Comparison of Charlson comorbidity index with SAPS and APACHE scores for prediction of mortality following intensive care , 2011, Clinical epidemiology.

[18]  H. Losert,et al.  Compromising bradycardia: management in the emergency department. , 2007, Resuscitation.

[19]  Paul C. Zei,et al.  Modified temporary cardiac pacing using transvenous active fixation leads and external re-sterilized pulse generators. , 2006, Journal of the American College of Cardiology.

[20]  G. Karth,et al.  Incidence and type of cardiac arrhythmias in critically ill patients: a single center experience in a medical-cardiological ICU , 2001, Intensive Care Medicine.

[21]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.